ODDB.org: Open Drug Database

A. Menarini GmbH - Ranexa 375 mg, Retardtabletten

Swissmedic Registration	60533	Sequence	01
Product name	Ranexa 375 mg	Description	Retardtabletten
ATC-Classification	C01EB18	ATC-Description	Ranolazine
Introduction of Sequence	13.04.2010

Composition

ranolazinum 375 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.15 mg, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, cera carnauba, E 171, E 132, pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Ranolazinum	375 mg

BAG: Active Agent	Dose
Ranolazinum	375 mg

Inactive agents	Dose	additional_information
Acidi Methacrylici
Cellulosum Microcristallinum
Cera Carnauba
E 132		color.
E 171		color.
Hypromellosum		Überzug
Macrogol	400
Magnesii Stearas
Methylis Methacrylatis Polymerisatum
Sodium Hydroxide
Polysorbatum 80
Pro Compresso Obducto

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30 Tablet(s)	PR	PR	B		Yes
002	60 Tablet(s)	46.44	66.90	B	SL	Yes
003	100 Tablet(s)	75.95	99.00	B	SL	Yes

2025	©ywesee GmbH